AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BeOne Medicines Ltd. Class A

¥253.56 -$47.33 (-15.73%)
SHH · 15 Sep 2026 07:00 UTC
Previous Close
¥256.6
Day Range
¥252.95¥257
Year Range
¥205.51¥325
Market Cap
265.16B
AVG Volume
5.29M
Trailing/Forward PE
25.28/328.45
PEG ratio
0.67
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
Shanghai Stock ExchangeCN
Revenue (USD)
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q21.71B
26 Q11.52B
25 Q41.52B
25 Q31.41B
25 Q21.32B
25 Q11.12B
24 Q41.19B
24 Q31.05B
24 Q2929.17M
24 Q1751.65M
Net Income (USD)
-400M-200M0200M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2237.01M
26 Q1228.74M
25 Q467.41M
25 Q3124.84M
25 Q294.32M
25 Q11.27M
24 Q4-139.7M
24 Q3-153.96M
24 Q2-120.41M
24 Q1-251.15M
Operating Income (USD)
-400M-200M0200M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2325.05M
26 Q1251.43M
25 Q4187.56M
25 Q3163.11M
25 Q287.89M
25 Q111.1M
24 Q4-100.92M
24 Q3-117.68M
24 Q2-107.16M
24 Q1-261.35M
EBITDA (USD)
-400M-200M0200M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2392.71M
26 Q1335.28M
25 Q4208.61M
25 Q3163.11M
25 Q2135.16M
25 Q152.53M
24 Q4-33.25M
24 Q3-121.73M
24 Q2-82.17M
24 Q1-219.32M
Cash Flows (USD)
-750M-500M-250M0250M500M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2414.83M
26 Q1160.55M
25 Q4387.68M
25 Q3354.47M
25 Q2199.77M
25 Q1-72.33M
24 Q4-17.32M
24 Q354.71M
24 Q2-205.54M
24 Q1-501.62M
EPS (USD)
-2.502.557.524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS EPS (USD) by quarter
PeriodEPS (USD)
26 Q20.16
26 Q10.15
25 Q40.04
25 Q31.09
25 Q26.45
25 Q10.01
24 Q4-1.31
24 Q3-1.47
24 Q2-1.15
24 Q1-2.47
Expenses (USD)
0500M1B1.5BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q21.25B
26 Q11.11B
25 Q41.19B
25 Q31.1B
25 Q21.13B
25 Q11.06B
24 Q41.13B
24 Q31.12B
24 Q21.01B
24 Q11.08B
Cash & Debt (USD)
02B4B6BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q25.1B
26 Q14.85B
25 Q44.58B
25 Q34.04B
25 Q22.76B
25 Q12.52B
24 Q42.63B
24 Q32.7B
24 Q22.59B
24 Q12.79B
Debt ratios
-60-40-2002024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS Debt ratios by quarter
PeriodDebt ratios
26 Q2-3.6
26 Q1-3.31
25 Q4-4.62
25 Q3-9.5
25 Q2-52.89
25 Q18.23
24 Q43.39
24 Q32.05
24 Q21.99
24 Q11.7
Margins
0%25%50%75%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS Margins by quarter
PeriodMargins
26 Q289.76%
26 Q186.63%
25 Q488.43%
25 Q386.09%
25 Q287.49%
25 Q185.23%
24 Q485.44%
24 Q383.28%
24 Q285.13%
24 Q183.38%
Return on Capital
-10%-5%0%5%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS Return on Capital by quarter
PeriodReturn on Capital
26 Q24.58%
26 Q14.79%
25 Q41.55%
25 Q33.02%
25 Q22.5%
25 Q10.04%
24 Q4-4.19%
24 Q3-4.48%
24 Q2-3.58%
24 Q1-7.47%
Shares Outstanding
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS Shares Outstanding by quarter
PeriodShares Outstanding
26 Q21.45B
26 Q11.44B
25 Q41.44B
25 Q3110.22M
25 Q2106.86M
25 Q1111.17M
24 Q4106.26M
24 Q3104.97M
24 Q2104.7M
24 Q1101.68M
Book Value Per Share (USD)
01020304024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q23.57
26 Q13.31
25 Q43.03
25 Q337.47
25 Q235.28
25 Q131.48
24 Q431.36
24 Q332.73
24 Q232.15
24 Q133.05
Total Assets (USD)
02.5B5B7.5B10B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
688235.SS Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q29.18B
26 Q18.59B
25 Q48.22B
25 Q37.63B
25 Q26.3B
25 Q15.84B
24 Q45.92B
24 Q35.83B
24 Q25.71B
24 Q15.67B
PE Ratio
050100150200med 106.58Nov 25Jan 26Mar 26Apr 26Jun 26Jul 26Sep 26
688235.SS PE Ratio by quarter
PeriodPE Ratio
Sep 26107.08
Sep 26103.2
Sep 26113.04
Aug 26113.08
Aug 26120.48
Aug 26119.48
Aug 26124.19
Jul 26106.58
Jul 26112.03
Jul 26103.49
Jul 26110.64
Jul 26110.23
Jun 26170.76
Jun 26161.24
Jun 26160.01
Jun 26162.77
May 26180.28
May 26180.02
May 26185.09
May 26182.02
Apr 26172
Apr 26171.83
Apr 26180.85
Apr 26178.82
Apr 26173.89
Mar 2645.96
Mar 2645.12
Mar 2645.27
Mar 2647.21
Feb 2651.3
Feb 2655.26
Feb 2653.61
Jan 2654.46
Jan 2656.74
Jan 2660.17
Jan 2661.25
Dec 2552.44
Dec 2553.6
Dec 2553.13
Dec 2553.51
Dec 2553.92
Nov 2555.9
Nov 2553.58
Nov 2557.46
Nov 2553.48
Free Cash Flow Yield
-60%-40%-20%0%20%med -1.6%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
688235.SS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 262%
Sep 262.07%
Sep 261.89%
Aug 261.89%
Aug 261.78%
Aug 261.79%
Aug 261.72%
Jul 262.01%
Jul 261.91%
Jul 262.07%
Jul 261.93%
Jul 261.94%
Jun 261.77%
Jun 261.87%
Jun 261.89%
Jun 261.86%
May 261.68%
May 261.68%
May 261.63%
May 261.66%
Apr 261.76%
Apr 261.76%
Apr 261.67%
Apr 261.69%
Apr 261.74%
Mar 2612.52%
Mar 2612.75%
Mar 2612.71%
Mar 2612.19%
Feb 2611.22%
Feb 2610.41%
Feb 2610.73%
Jan 2610.57%
Jan 2610.14%
Jan 269.56%
Jan 269.4%
Dec 2510.97%
Dec 2510.74%
Dec 2510.83%
Dec 2510.75%
Dec 2510.67%
Nov 2510.29%
Nov 2510.74%
Nov 2510.01%
Nov 2510.76%
Oct 253.7%
Oct 253.93%
Oct 254.02%
Oct 253.85%
Sep 253.58%
Sep 25-5.11%
Sep 25-4.96%
Sep 25-4.88%
Sep 25-4.82%
Aug 25-5.55%
Aug 25-6.27%
Aug 25-6.44%
Aug 25-6.92%
Aug 25-6.56%
Jul 25-6.6%
Jul 25-6.22%
Jul 25-6.74%
Jul 25-6.75%
Jun 25-19.15%
Jun 25-18.42%
Jun 25-17.6%
Jun 25-19.22%
May 25-19.71%
May 25-19.59%
May 25-19.71%
May 25-18.73%
Apr 25-17.55%
Apr 25-19.21%
Apr 25-19.36%
Apr 25-19.53%
Apr 25-18.3%
Mar 25-31.13%
Mar 25-32.09%
Mar 25-33.29%
Mar 25-31.16%
Feb 25-30.29%
Feb 25-32.1%
Feb 25-36.38%
Feb 25-37.06%
Jan 25-37.71%
Jan 25-38.01%
Jan 25-39.87%
Jan 25-45.26%
Jan 25-45.5%
Dec 24-57.64%
Dec 24-58.62%
Dec 24-58.17%
Dec 24-54.65%
Nov 24-51.72%
Nov 24-56.39%
Nov 24-56.65%
Nov 24-51.27%
Nov 24-54.74%
Oct 24-53.43%
Oct 24-51.04%
Price to Sales
051015med 0.9Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
688235.SS Price to Sales by quarter
PeriodPrice to Sales
Sep 269.57
Sep 269.22
Sep 2610.1
Aug 2610.1
Aug 2610.76
Aug 2610.67
Aug 2611.09
Jul 269.52
Jul 2610.01
Jul 269.24
Jul 269.88
Jul 269.85
Jun 269.16
Jun 268.65
Jun 268.59
Jun 268.74
May 269.68
May 269.66
May 269.93
May 269.77
Apr 269.23
Apr 269.22
Apr 269.71
Apr 269.6
Apr 269.33
Mar 260.74
Mar 260.72
Mar 260.73
Mar 260.76
Feb 260.82
Feb 260.89
Feb 260.86
Jan 260.87
Jan 260.91
Jan 260.97
Jan 260.98
Dec 250.84
Dec 250.86
Dec 250.85
Dec 250.86
Dec 250.86
Nov 250.9
Nov 250.86
Nov 250.92
Nov 250.86
Oct 250.95
Oct 250.9
Oct 250.88
Oct 250.92
Sep 250.99
Sep 251.1
Sep 251.13
Sep 251.15
Sep 251.16
Aug 251.01
Aug 250.9
Aug 250.87
Aug 250.81
Aug 250.86
Jul 250.85
Jul 250.9
Jul 250.83
Jul 250.83
Jun 250.89
Jun 250.93
Jun 250.97
Jun 250.89
May 250.87
May 250.87
May 250.87
May 250.91
Apr 250.97
Apr 250.89
Apr 250.88
Apr 250.88
Apr 250.93
Mar 250.99
Mar 250.96
Mar 250.93
Mar 250.99
Feb 251.02
Feb 250.96
Feb 250.85
Feb 250.83
Jan 250.82
Jan 250.81
Jan 250.77
Jan 250.68
Jan 250.68
Dec 240.77
Dec 240.76
Dec 240.77
Dec 240.81
Nov 240.86
Nov 240.79
Nov 240.79
Nov 240.87
Nov 240.81
Oct 240.83
Oct 240.87
EV/EBITDA
0255075100med 64.26Oct 25Dec 25Jan 26Apr 26May 26Jul 26Sep 26
688235.SS EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2662.21
Sep 2659.84
Sep 2665.85
Aug 2665.88
Aug 2670.41
Aug 2669.79
Aug 2672.68
Jul 2661.9
Jul 2665.24
Jul 2660.01
Jul 2664.39
Jul 2664.14
Jun 2683.24
Jun 2678.34
Jun 2677.71
Jun 2679.13
May 2688.14
May 2688.01
May 2690.61
May 2689.03
Apr 2683.88
Apr 2683.79
Apr 2688.43
Apr 2687.38
Apr 2684.85
Mar 262.19
Mar 261.97
Mar 262.01
Mar 262.5
Feb 263.54
Feb 264.55
Feb 264.13
Jan 264.34
Jan 264.92
Jan 265.8
Jan 266.07
Dec 253.83
Dec 254.13
Dec 254.01
Dec 254.1
Dec 254.21
Nov 254.71
Nov 254.12
Nov 255.11
Nov 254.1
Oct 2583.31
Oct 2575.46
Oct 2572.55
Oct 2577.88
Sep 2587.93
Price/Operating Cashflow
0204060med 18.1Aug 25Oct 25Dec 25Mar 26May 26Jul 26Sep 26
688235.SS Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2642.68
Sep 2641.13
Sep 2645.05
Aug 2645.07
Aug 2648.01
Aug 2647.61
Aug 2649.49
Jul 2642.48
Jul 2644.65
Jul 2641.25
Jul 2644.09
Jul 2643.93
Jun 2643.28
Jun 2640.86
Jun 2640.55
Jun 2641.25
May 2645.69
May 2645.62
May 2646.91
May 2646.13
Apr 2643.59
Apr 2643.55
Apr 2645.83
Apr 2645.32
Apr 2644.07
Mar 264.72
Mar 264.64
Mar 264.65
Mar 264.85
Feb 265.27
Feb 265.68
Feb 265.51
Jan 265.6
Jan 265.83
Jan 266.19
Jan 266.3
Dec 255.39
Dec 255.51
Dec 255.46
Dec 255.5
Dec 255.54
Nov 255.75
Nov 255.51
Nov 255.91
Nov 255.5
Oct 257.8
Oct 257.35
Oct 257.18
Oct 257.49
Sep 258.07
Sep 2522.19
Sep 2522.86
Sep 2523.23
Sep 2523.51
Aug 2520.44
Aug 2518.1
Aug 2517.61
Aug 2516.4
Aug 2517.3
Jul 2517.18
Jul 2518.25
Jul 2516.82
Jul 2516.81
Price to Book
051015med 1.06Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
688235.SS Price to Book by quarter
PeriodPrice to Book
Sep 2611.55
Sep 2611.13
Sep 2612.19
Aug 2612.2
Aug 2612.99
Aug 2612.88
Aug 2613.39
Jul 2611.49
Jul 2612.08
Jul 2611.16
Jul 2611.93
Jul 2611.89
Jun 2611.28
Jun 2610.65
Jun 2610.57
Jun 2610.75
May 2611.91
May 2611.89
May 2612.23
May 2612.03
Apr 2611.36
Apr 2611.35
Apr 2611.95
Apr 2611.81
Apr 2611.49
Mar 260.9
Mar 260.88
Mar 260.89
Mar 260.92
Feb 261
Feb 261.08
Feb 261.05
Jan 261.06
Jan 261.11
Jan 261.18
Jan 261.2
Dec 251.03
Dec 251.05
Dec 251.04
Dec 251.05
Dec 251.05
Nov 251.09
Nov 251.05
Nov 251.12
Nov 251.05
Oct 251.18
Oct 251.11
Oct 251.09
Oct 251.13
Sep 251.22
Sep 251.34
Sep 251.39
Sep 251.41
Sep 251.42
Aug 251.24
Aug 251.1
Aug 251.07
Aug 250.99
Aug 251.05
Jul 251.04
Jul 251.11
Jul 251.02
Jul 251.02
Jun 251.05
Jun 251.09
Jun 251.14
Jun 251.05
May 251.02
May 251.03
May 251.02
May 251.07
Apr 251.15
Apr 251.05
Apr 251.04
Apr 251.03
Apr 251.1
Mar 250.97
Mar 250.94
Mar 250.91
Mar 250.97
Feb 251
Feb 250.94
Feb 250.83
Feb 250.82
Jan 250.8
Jan 250.8
Jan 250.76
Jan 250.67
Jan 250.67
Dec 240.7
Dec 240.69
Dec 240.69
Dec 240.74
Nov 240.78
Nov 240.71
Nov 240.71
Nov 240.79
Nov 240.74
Oct 240.75
Oct 240.79
BeOne Medicines Ltd. Class A
688235.SS
Stockpicker

Video analysis: 688235.SS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.